Get started
Author

Avinash D. Khadela

Observed names: A. Khadela, A.D. Khadela, Avinash Khadela, Khadela, Avinash
Observed institutions: Gujarat University, JSS Academy of Higher Education and Research, Uka Tarsadia University, Gujarat Technological University, JSS College of Pharmacy, Parul University
ORCID: 0000-0001-9914-8539
Observed ORCID: 0000-0001-9914-8539
OpenAlex ID: A5082658710
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer
2023 · Vivek P. Chavda, Lakshmi Vineela Nalla, et al. · Cancers · 124
PDF
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
2022 · Vivek Chavda, Shailvi Soni, et al. · Vaccines · 89
PDF
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
2023 · Vivek P. Chavda, Vrashabh V. Sugandhi, et al. · Journal of Drug Delivery Science and Technology · 44
PDF
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response
2022 · Avinash Khadela, Vivek P. Chavda, et al. · Vaccines · 42
PDF
Current status of Cancer Nanotheranostics: Emerging strategies for cancer management
2023 · Vivek P Chavda, Avinash Khadela, et al. · Nanotheranostics · 38
PDF
In vitro and in vivo evaluation of cyclosporine-graphene oxide laden hydrogel contact lenses
2021 · Ditixa T. Desai, Furqan A. Maulvi, et al. · International Journal of Pharmaceutics · 36
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
2023 · Vivek Chavda, Kelsee K. Zajac, et al. · Cancer Reports · 26
PDF
A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer
2023 · Avinash Khadela, Humzah Postwala, et al. · Medical Oncology · 24
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
2022 · Avinash Khadela, Vivek P. Chavda, et al. · Cancers · 23
PDF
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects
2023 · Avinash Khadela, Yesha Shah, et al. · Technology in Cancer Research & Treatment · 21
PDF
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer
2023 · Avinash Khadela, Vivek P. Chavda, et al. · Cancers · 18
PDF
Unveiling the antibody–drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon
2022 · Avinash Khadela, Shruti Soni, et al. · Medical Oncology · 18
AI, ML and Other Bioinformatics Tools for Preclinical and Clinical Development of Drug Products
2023 · Avinash Khadela, Sagar Popat, et al. · Wiley eBooks · 17
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects
2022 · Avinash Khadela, Shruti Soni, et al. · Medical Oncology · 16
PDF
A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer
2022 · Avinash Khadela, Yesha Shah, et al. · Medical Oncology · 15
Impact of clinical pharmacist services on quality adjusted life years in head and neck cancer patients
2021 · Avinash Khadela, Bhavin Vyas, et al. · International Journal of Clinical Pharmacy · 14
Impact of oncology pharmacist services on humanistic outcome in patients with breast cancer
2021 · Avinash Khadela, Vishal Bhikadiya, et al. · Journal of Oncology Pharmacy Practice · 13
Assessment of the utilization pattern of chemotherapy agents in patients with head and neck cancer in an oncology hospital
2020 · Avinash Khadela, Bhavin Vyas · Drugs & Therapy Perspectives · 12
Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers
2024 · Avinash Khadela, Kaivalya Megha, et al. · Clinical Medicine Insights Oncology · 11
Sacituzumab govitecan in HER2-negative breast cancer: redefining treatment paradigms
2025 · Avinash Khadela, Kashvy R. Morakhia, et al. · Journal of drug targeting · 10
A comprehensive review comparing conventional versus traditional remedies in the treatment of endometriosis with futuristic insights
2024 · Mansi Shah, Bhavarth Dave, et al. · Future Journal of Pharmaceutical Sciences · 10
PDF
A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities
2023 · Avinash Khadela, Shruti Soni, et al. · Biologics · 9
PDF
Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer
2025 · Shruti Soni, Kaivalya Megha, et al. · Journal of the Egyptian National Cancer Institute · 8
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer
2023 · Avinash Khadela, Bhavin Vyas, et al. · Journal of the Egyptian National Cancer Institute · 7
PDF
Current Perspectives in Dengue Hemorrhagic Fever
2024 · Manish P. Patel, Vaishnavi M. Oza, et al. · Wiley eBooks · 6
Works count: 70
Citation count: 709
H-index: 15
I10-index: 21
Year
Topic
Type